Artist selected to deliver new creative installation for Cambridge Cancer Research Hospital

A major public art commission has been announced today for the new Cambridge Cancer Research Hospital. Acclaimed artist Ivan Morison is working in collaboration with patients and staff to design a large scale sculpture — using clay from the East of England historic clay pits — for the foyer of the new hospital, planned for the Cambridge Biomedical Campus.

Cambridge Science Park submits masterplan to unlock the region's potential

Cambridge Science Park submits its masterplan for planning consent, continuing its commitment to a site that has been a cornerstone of the Cambridge phenomenon over the past 50 years. The plan is entirely privately funded, increasing built space from 2.8 million to approximately 8 million square feet.

When the conversation stalls

Readiness and International Engagement in Life Sciences.

Acteon launches AI training informed by behavioural science and AI best practice

Behaviour change consultancy Acteon has released free TikTok style training helping employees use AI safely, effectively and confidently. Free to download now.

Oxford’s West End a new frontier of homegrown science, says Science Minister Vallance

Oxford’s West End is emerging as a new frontier of British science and technology, the Minister for Science, Research and Innovation said on Thursday, lending support to a £600 million vision that will see the emergence of a new urban district providing critical infrastructure for UK innovation.

The EpiCentre expands laboratory capabilities with new advanced equipment

Haverhill, UK — [14th May 2026] — The EpiCentre announces a major enhancement to its laboratory offering with the introduction of two advanced pieces of scientific equipment: a fluorescent microscope and a quantitative PCR (qPCR) machine. The investment has been made possible through grant support from West Suffolk Council via the UK Shared Prosperity Fund.

Turning your Life Sciences leads into long-term commercial value

Learn how aligning content, channels and automation through lead mapping can unlock better performance across the funnel.

Sapphire Digital Health Advisory joins Cambridge Network

Sapphire Digital Health Advisory Ltd is pleased to join Cambridge Network as part of our commitment to collaboration, innovation and responsible digital health transformation.

Qureight to support Mediar Therapeutics’ Phase 2 trial of MTX-474 in diffuse cutaneous Systemic Sclerosis

Qureight’s AI-powered quantitative imaging analytics platform and services to analyse HRCT images to evaluate changes in compartment-specific lung biomarkersThe focus of these efforts will be on the quantitative assessment of change from baseline in lung fibrosis

Reduce sickness absence, retain staff and increase productivity in your business

As it is Mental Health Awareness Week, it’s a perfect opportunity for me to reintroduce myself.

Enterprise Therapeutics achieves primary efficacy outcome in Phase 2 clinical trial for cystic fibrosis with novel inhaled ENaC blocker ETD001

First investigational inhaled ENaC blocker to deliver clinically relevant and statistically significant change in lung function compared to placebo Inhaled therapeutic designed to treat the 10% of people with cystic fibrosis with the highest unmet medical need

Alfa Corporate Finance advises on the sale of Cambridge based Blue Scientific to Aptco Group

Alfa Corporate Finance has advised on the sale of BlueScientific to Aptco Group, supporting the shareholders from initial strategic review through to buyer selection, negotiation and completion. The transaction enables BlueScientific to join a broader pan-European platform while retaining leadership continuity, and was structured to balance value, cultural alignment and long-term growth.

How IT directors can finally get ahead of tickets

Is your ticket queue ever truly completed?

Or is it just quiet enough for you to breathe before the next wave hits?

From where we sit, tickets are rarely the real problem. They’re the visible symptom.

A weekend in Cambridge - Exclusive for families and partners of The University Arms and Cambridge Network

University Arms Cambridge is opening its doors to the families and guests of our corporate partners. Indulge with 30% off B&B on Friday, Saturday, and Sunday nights, a welcome drink on arrival, and breakfast included. Available by invitation only. Email [email protected] to book.

Nuclera launches antibody triage service to advance AI-driven antibody discovery

Rapid binder triage, of AI-driven candidate sets, enables early elimination of non-binders ahead of costly downstream workflowsPowered by cell-free technology to convert AI-generated candidates into experimental binding data

Cambridge, UK and Bo

Guardtech unveil revamped Isopod Configurator online cleanroom pod builder tool

The East Anglian cleanroom construction specialists have given their revolutionary ‘build your own cleanroom’ software a facelift to further enhance users’ procurement journey

Cambridge NeuroWorks named “Tech for Good” winner for advancing breakthrough neurotechnology

Cambridge NeuroWorks has been named winner of the “Tech for Good” Award at the Cambridge Independent Science & Technology Awards 2026, recognising its rapid progress in accelerating breakthrough neurotechnologies with the potential to transform millions of lives.

Cambridge University Hospitals announces Nicola Ayton as Chief Executive

Cambridge University Hospitals NHS Foundation Trust (CUH) has appointed Nicola Ayton as Chief Executive, following a competitive recruitment process. She had been serving as interim Chief Executive since 1 January 2026.

Nuala McBride joins Salus Wellness

Nuala McBride is a degree-qualified nutritionist registered under the UK's Association for Nutrition.

Clement Mind presents at UKABIF 2026: Managing Challenging Behaviours after Acquired Brain Injury

Dr Alberto Bonilla Miralles, Clinical & Occupational Psychologist and Director at Clement Mind, delivered a specialist presentation at the UK Acquired Brain Injury Forum (UKABIF) on evidence-based approaches to understanding and managing challenging behaviours following an acquired brain injury.

12 gene therapies converge on retinitis pigmentosa and a $3.4bn market by 2033

This month Gene Scope Intelligence (www.genescope-intelligence.com), a dedicated gene therapy market intelligence platform releases a brand new commercial analysis and demand forecast for new gene therapies directed at Retinitis Pigmentosa (RP).

Calla Lily Clinical Care doses first patients in clinical trial for intravaginal drug delivery platform for threatened miscarriage

FREEDOM study to evaluate progesterone delivery using Callavid intravaginal platformNIHR-funded trial in collaboration with University Hospitals Coventry and Warwickshire NHS Trust

London, UK, 06 May 2026: Calla Lily Clinical Care, a wo

FUJIFILM Biosciences and NextCell launch new commercial platform comprised of RUO Stromal Cells and Cell Culture Media

Collaboration results in platform to help researchers overcome challenges in MSC research

Bio-Rad expands range of TrailBlazer Kits for Antibody Conjugation to StarBright Dyes

Expanded Range Increases Access to Bio-Rad’s StarBright™ Dyes for Flow Cytometry and Western Blot Applications in Immunology Research

Beware the next generation of phishing attacks

If phishing scams are supposed to trick people, why do so many of them still feel clumsy?

For years, the answer was simple: Most scams were mass-produced.